DE69430079D1 - Verfahren zur Herstellung von Oenothein-B aus Epilobium Parviflorum - Google Patents

Verfahren zur Herstellung von Oenothein-B aus Epilobium Parviflorum

Info

Publication number
DE69430079D1
DE69430079D1 DE69430079T DE69430079T DE69430079D1 DE 69430079 D1 DE69430079 D1 DE 69430079D1 DE 69430079 T DE69430079 T DE 69430079T DE 69430079 T DE69430079 T DE 69430079T DE 69430079 D1 DE69430079 D1 DE 69430079D1
Authority
DE
Germany
Prior art keywords
oenothein
production
epilobium parviflorum
parviflorum
epilobium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69430079T
Other languages
English (en)
Other versions
DE69430079T2 (de
Inventor
Jean-Francois Gourvest
Alexander Kasal
Dominique Lesuisse
Jean-Georges Teutsch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Application granted granted Critical
Publication of DE69430079D1 publication Critical patent/DE69430079D1/de
Publication of DE69430079T2 publication Critical patent/DE69430079T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
DE69430079T 1993-11-16 1994-11-15 Verfahren zur Herstellung von Oenothein-B aus Epilobium Parviflorum Expired - Lifetime DE69430079T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9313623A FR2712495B1 (fr) 1993-11-16 1993-11-16 Application de l'Óoenotheine B pour obtenir un médicament destiné au traitement des troubles liés à l'hyperandrogénie, et les compositions pharmaceutiques le contenant.

Publications (2)

Publication Number Publication Date
DE69430079D1 true DE69430079D1 (de) 2002-04-11
DE69430079T2 DE69430079T2 (de) 2002-08-14

Family

ID=9452879

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69430079T Expired - Lifetime DE69430079T2 (de) 1993-11-16 1994-11-15 Verfahren zur Herstellung von Oenothein-B aus Epilobium Parviflorum
DE69423577T Expired - Lifetime DE69423577T2 (de) 1993-11-16 1994-11-15 Verwendung von Oenothein B zur Herstellung eines Medikaments zur Behandlung der durch Hyperandrogenität bedingte Störungen.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69423577T Expired - Lifetime DE69423577T2 (de) 1993-11-16 1994-11-15 Verwendung von Oenothein B zur Herstellung eines Medikaments zur Behandlung der durch Hyperandrogenität bedingte Störungen.

Country Status (5)

Country Link
US (1) US5525594A (de)
EP (2) EP0657167B1 (de)
JP (2) JP3958803B2 (de)
DE (2) DE69430079T2 (de)
FR (1) FR2712495B1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2712594B1 (fr) * 1993-11-16 1996-12-27 Roussel Uclaf Procédé de préparation de l'oenotheine B à partir d'Epilobium Parviflorum.
US5879711A (en) * 1997-11-07 1999-03-09 Sequeira; Joel A. Stable antiandrogenic gel composition
US20010024664A1 (en) * 1999-03-19 2001-09-27 Obukowicz Mark G. Selective COX-2 inhibition from edible plant extracts
FR2791255B1 (fr) * 1999-03-26 2003-05-16 Greentech Sa Complexe vegetal entrant dans des compositions cosmetiques et dermopharmaceutiques limitant le developpement du bulbe pileux, stimulant le systeme capillaire et s'utilisant pour le traitement des peaux seborrheiques
CA2282185A1 (en) * 1999-09-10 2001-03-10 Warren Steck Oenothein medicaments
CA2421761C (en) 2000-09-12 2009-09-01 The Nikka Whisky Distilling Co., Ltd. Crab apple fruit polyphenol and production process thereof
AUPR600601A0 (en) * 2001-07-05 2001-07-26 Greenhaven Limited Therapeutic compositions
GB0205826D0 (en) * 2002-03-13 2002-04-24 Bryant Andrew E Therapeutic compositions and methods
WO2006058430A1 (en) * 2004-12-02 2006-06-08 Testa Hair Holdings Inc. Composition for treating hair and scalp and method for preparing same
US20070009621A1 (en) * 2005-07-07 2007-01-11 Annie Eng Correcting systemic androgen levels using Eurycoma longifolia
FR3099701B1 (fr) * 2019-08-08 2022-03-25 BASF Beauty Care Solutions FR Nouvelle utilisation cosmétique d’une combinaison d’oenothéine-B et de quercétine-3-O-glucuronide
KR102376806B1 (ko) * 2020-03-05 2022-03-21 주식회사 메타이뮨텍 오에노테인 b 유사체를 유효성분으로 포함하는 체중 감량용 조성물
CN114315923A (zh) * 2022-01-13 2022-04-12 青海民族大学 一种柳兰水提物中获得月见草素b有效部位方法及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62129220A (ja) * 1985-11-30 1987-06-11 Riide Chem Kk 制癌剤
JPS646289A (en) * 1987-06-29 1989-01-10 Lead Chem Co Ltd Pharmaceutical composition for remedy and crisis-prevention of acquired immunodeficiency syndrome

Also Published As

Publication number Publication date
JP4249732B2 (ja) 2009-04-08
US5525594A (en) 1996-06-11
EP0947522B1 (de) 2002-03-06
DE69423577T2 (de) 2000-09-21
DE69430079T2 (de) 2002-08-14
JPH07188275A (ja) 1995-07-25
EP0947522A2 (de) 1999-10-06
EP0657167A3 (de) 1995-10-25
FR2712495A1 (fr) 1995-05-24
EP0657167B1 (de) 2000-03-22
EP0947522A3 (de) 2000-03-15
JP2005255693A (ja) 2005-09-22
JP3958803B2 (ja) 2007-08-15
FR2712495B1 (fr) 1996-01-05
EP0657167A2 (de) 1995-06-14
DE69423577D1 (de) 2000-04-27

Similar Documents

Publication Publication Date Title
DE69527818D1 (de) Verfahren zur Herstellung von Polycarbonaten
DE69508310D1 (de) Verfahren zur Herstellung von Mikrolinsen
DE69226224T2 (de) Verfahren zur Herstellung von Chitosan
DE69415722D1 (de) Verfahren zur Herstellung von Polycarbonaten
DE59506573D1 (de) Verfahren zur Herstellung von Filtern
DE69510596D1 (de) Verfahren zur Herstellung von Organooxysilane
DE69611484D1 (de) Verfahren zur Herstellung von Phenol
DE69430079D1 (de) Verfahren zur Herstellung von Oenothein-B aus Epilobium Parviflorum
DE59500545D1 (de) Verfahren zur adiabatischen Herstellung von Mononitrotoluolen
DE69217346T2 (de) Verfahren zur Herstellung von Mikroleuchtkörpern
DE69213916D1 (de) Verfahren zur Herstellung von L-Ambrox
DE69310232D1 (de) Verfahren zur Herstellung von Organomonochlorsilan
DE59506135D1 (de) Verfahren zur adiabatischen Herstellung von Mononitrohalogenbenzolen
DE69412302D1 (de) Verfahren zur Herstellung von Polyolefinen
ATE107935T1 (de) Verfahren zur herstellung von propylen-ethylen- copolymerisaten.
DE59302489D1 (de) Verfahren zur Herstellung von Chlor-Fluor-Butenen
DE69406342T2 (de) Verfahren zur Herstellung von Filterzigaretten
DE69611331T2 (de) Verfahren zur Herstellung von S-Phenyl-L-Cystein
DE69603243D1 (de) Verfahren zur Herstellung von Ethenylamiden
DE69008697D1 (de) Verfahren zur Herstellung von Pentafluordichlorpropanen.
DE59501484D1 (de) Verfahren zur Herstellung von Salcomin
DE69405630D1 (de) Verfahren zur Herstellung von Filterzigaretten
DE69424897D1 (de) Verfahren zur Herstellung von Ortho-estern
DE69433495D1 (de) Verfahren zur Herstellung von Polycarbonaten
DE69402622T2 (de) Verfahren zur Herstellung von Hydrofluorkohlenstoffen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC